Anti-Inflammatory Action of Sitagliptin and Linagliptin in Doxorubicin Nephropathy

Chor Ho Jo, Sua Kim, Joon-Sung Park, Gheun‐Ho Kim

Kidney & Blood Pressure Research · 2018 · 55 citations · 40 references

DOIFull text

Open access

Abstract

NLRP3 inflammasome activation was shown in our rat model of doxorubicin nephropathy. DPP4 inhibitors can suppress the activity of NLRP3, with or without relieving NADPH oxidase 2-related oxidative stress.

References

40